The GINA 2024 Diagnosis and Management of Difficult-to-treat & Severe Asthma Guide is now available to download. 2024 GINA Difficult-to-treat & Severe Asthma Guide The GINA 2024 Summary Guide, (formerly…
Wongsa, Chamard et al. Journal of Allergy and Clinical Immunology: Global, Volume 0, Issue 0, 100366 Abstract Background Inhaled corticosteroid (ICS) containing regimens are the mainstay for treating asthma despite…
Mauclin M, Guillien A, Niespodziana K et al. J Allergy Clin Immunol Glob. 2024 Sep 17;4(1):100342. doi: 10.1016/j.jacig.2024.100342. AbstractBackground: Viral infections in childhood, especially to rhinovirus (RV) and respiratory syncytial…
Buhumaid, R., Alzaabi, A., Mahboub, B. et al. Int J Emerg Med 17, 172 (2024). https://doi.org/10.1186/s12245-024-00757-4 Abstract Background Asthma is a common chronic respiratory inflammatory disease that adversely affects patients’…
Sharma, R., Tiwari, A., Kho, A.T. et al. BMC Pulm Med 24, 553 (2024). https://doi.org/10.1186/s12890-024-03372-4 Abstract Background Bronchodilator response (BDR) is a measure of improvement in airway smooth muscle tone, inhibition of liquid…
Rayner DG, Ferri DM, Guyatt GH, O’Byrne PM, et al. JAMA. 2024 Oct 28. doi: 10.1001/jama.2024.22700. Key Points Question In people with asthma, compared with short-acting β agonists (SABA) alone, is…
Ni, Ruijing et al.One Earth, Volume 0, Issue 0 Science for society Asthma is currently an incurable disease that severely impairs quality of life, with recurring symptoms such as wheezing,…
Punyadasa, D., Adderley, N.J., Rudge, G. et al. BMC Public Health 24, 2915 (2024). https://doi.org/10.1186/s12889-024-20418-8 Abstract Background The indoor home environment plays a crucial role in determining the outcome of respiratory diseases, including…
Yorgancıoğlu, A., Aksu, K., Cura, C. et al. BMC Pulm Med 24, 524 (2024). https://doi.org/10.1186/s12890-024-03327-9 Abstract Background This cost of illness study aimed to determine economic burden of short-acting β2-agonist (SABA) overuse in…